These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 33741354)

  • 41. Epidermal growth factor receptor coexpression modulates susceptibility to Herceptin in HER2/neu overexpressing breast cancer cells via specific erbB-receptor interaction and activation.
    Diermeier S; Horváth G; Knuechel-Clarke R; Hofstaedter F; Szöllosi J; Brockhoff G
    Exp Cell Res; 2005 Apr; 304(2):604-19. PubMed ID: 15748904
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Activation of erbB2 and c-src in phorbol ester-treated mouse epidermis: possible role in mouse skin tumor promotion.
    Xian W; Rosenberg MP; DiGiovanni J
    Oncogene; 1997 Mar; 14(12):1435-44. PubMed ID: 9136987
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Receptor tyrosine kinase ERBB4 mediates acquired resistance to ERBB2 inhibitors in breast cancer cells.
    Canfield K; Li J; Wilkins OM; Morrison MM; Ung M; Wells W; Williams CR; Liby KT; Vullhorst D; Buonanno A; Hu H; Schiff R; Cook RS; Kurokawa M
    Cell Cycle; 2015; 14(4):648-55. PubMed ID: 25590338
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Emerging issues of connexin channels: biophysics fills the gap.
    Harris AL
    Q Rev Biophys; 2001 Aug; 34(3):325-472. PubMed ID: 11838236
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis.
    Xu M; Ren Z; Wang X; Comer A; Frank JA; Ke ZJ; Huang Y; Zhang Z; Shi X; Wang S; Luo J
    Mol Cancer; 2016 Jul; 15(1):52. PubMed ID: 27416801
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells.
    Qiu Y; Ravi L; Kung HJ
    Nature; 1998 May; 393(6680):83-5. PubMed ID: 9590694
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sensitivity of mature Erbb2 to geldanamycin is conferred by its kinase domain and is mediated by the chaperone protein Hsp90.
    Xu W; Mimnaugh E; Rosser MF; Nicchitta C; Marcu M; Yarden Y; Neckers L
    J Biol Chem; 2001 Feb; 276(5):3702-8. PubMed ID: 11071886
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Kinase activator-receiver preference in ErbB heterodimers is determined by intracellular regions and is not coupled to extracellular asymmetry.
    Ward MD; Leahy DJ
    J Biol Chem; 2015 Jan; 290(3):1570-9. PubMed ID: 25468910
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trastuzumab-induced recruitment of Csk-homologous kinase (CHK) to ErbB2 receptor is associated with ErbB2-Y1248 phosphorylation and ErbB2 degradation to mediate cell growth inhibition.
    Dokmanovic M; Wu Y; Shen Y; Chen J; Hirsch DS; Wu WJ
    Cancer Biol Ther; 2014 Aug; 15(8):1029-41. PubMed ID: 24835103
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Processive phosphorylation of p130Cas by Src depends on SH3-polyproline interactions.
    Pellicena P; Miller WT
    J Biol Chem; 2001 Jul; 276(30):28190-6. PubMed ID: 11389136
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
    Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
    Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ErbB/HER receptor protein-tyrosine kinases and cancer.
    Roskoski R
    Biochem Biophys Res Commun; 2004 Jun; 319(1):1-11. PubMed ID: 15158434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Phosphorylation of the multifunctional signal transducer B-cell adaptor protein (BCAP) promotes recruitment of multiple SH2/SH3 proteins including GRB2.
    Lauenstein JU; Udgata A; Bartram A; De Sutter D; Fisher DI; Halabi S; Eyckerman S; Gay NJ
    J Biol Chem; 2019 Dec; 294(52):19852-19861. PubMed ID: 31527084
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The efficacy of ErbB receptor-targeted anticancer therapeutics is influenced by the availability of epidermal growth factor-related peptides.
    Motoyama AB; Hynes NE; Lane HA
    Cancer Res; 2002 Jun; 62(11):3151-8. PubMed ID: 12036928
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complexity of signal transduction mediated by ErbB2: clues to the potential of receptor-targeted cancer therapy.
    Nagy P; Jenei A; Damjanovich S; Jovin TM; Szölôsi J
    Pathol Oncol Res; 1999; 5(4):255-71. PubMed ID: 10607920
    [TBL] [Abstract][Full Text] [Related]  

  • 57. VRK2 inhibits mitogen-activated protein kinase signaling and inversely correlates with ErbB2 in human breast cancer.
    Fernández IF; Blanco S; Lozano J; Lazo PA
    Mol Cell Biol; 2010 Oct; 30(19):4687-97. PubMed ID: 20679487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Recycling of EGFR and ErbB2 is associated with impaired Hrs tyrosine phosphorylation and decreased deubiquitination by AMSH.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2012 Nov; 24(11):1981-8. PubMed ID: 22800866
    [TBL] [Abstract][Full Text] [Related]  

  • 59. ErbB2 is necessary for induction of carcinoma cell invasion by ErbB family receptor tyrosine kinases.
    Spencer KS; Graus-Porta D; Leng J; Hynes NE; Klemke RL
    J Cell Biol; 2000 Jan; 148(2):385-97. PubMed ID: 10648571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional isolation of activated and unilaterally phosphorylated heterodimers of ERBB2 and ERBB3 as scaffolds in ligand-dependent signaling.
    Zhang Q; Park E; Kani K; Landgraf R
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13237-42. PubMed ID: 22733765
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.